Skincare Mondays | Data-Driven Dermatology Improves Patient Outcomes
Data-Driven Dermatology Improves Patient Outcomes
The use of real-world data and real-world evidence to inform health care decisions is increasing. While randomized controlled trials (RCTs) are still the gold standard for evidence-based medicine, the strict inclusion/exclusion criteria and tightly controlled conditions limit their generalizability to real-world clinical practice. Real worl …
Data-Driven Dermatology Improves Patient Outcomes
The use of real-world data and real-world evidence to inform health care decisions is increasing. While randomized controlled trials (RCTs) are still the gold standard for evidence-based medicine, the strict inclusion/exclusion criteria and tightly controlled conditions limit their generalizability to real-world clinical practice. Real worl … Continue reading "Skincare Mondays | Data-Driven Dermatology Improves Patient Outcomes"
Dr. Lawrence F. Eichenfield, meeting co-chair for the 17th Annual Women’s and Pediatric Dermatology Seminar, kicked off session III with a superb talk titled “Scaling the Heights…and Below, Pediatric Scaling Diseases: Psoriasis and Others”, giving us a bird’s eye view on the old and the new regarding pediatric psoriasis.
Dr. Eichenfield is a complete rock star and served as a valued … 
For most consumers, a skincare routine is a positive part of their daily routine. Thirty-eight percent (38%) see it as ‘me’ time. Sixty-three percent (63%) wash their face at least two times per day,1 yet roughly half of consumers (men and women) report using bath wash or hand soap to cleanse their face.2
So it's no surprise that over half of consumers surveyed have no idea what ingredients … 
Wow! The ODAC Dermatology Conference in January 2022 highlighted the importance of conference attendance and the need for expert lectures on clinically relevant dermatologic topics. We are in an era when basic sciences and translational research has direct correlation and impact on our therapeutic measures for patients. While it is refreshing to have so many options for patients’ treatment, it … 
While we have an increasing armamentarium of biologic agents and targeted systemic medications for certain dermatologic conditions such as psoriasis or atopic dermatitis, treatment options are still limited for a litany of other inflammatory cutaneous disorders. Additionally, when discussing therapeutic options, patients often opt for medications that are established, safe, well-tolerated and mini … 